Key result
VA-ECMO successfully bridges adrenal lesion-induced refractory cardiogenic shock to definitive treatment.
Why the study?
A minority of adrenal lesions can cause life-threatening cardiovascular crisis, where VA-ECMO may temporarily provide life support.
Case Report (n=28)
VA-ECMO can serve as an effective life-saving bridge to recovery and definitive surgical treatment in patients presenting with refractory cardiogenic shock caused by adrenal lesions such as pheochromocytoma.
May support VA-ECMO bridging in rare adrenal lesion shock; hypothesis-generating and leaves open need for prospective validation.
BackgroundMost adrenal disorders have an insidious onset and are not severe. Only a minority of adrenal lesions can lead to life-threatening cardiovascular crisis. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is an extracorporeal life support technology that can partially replace human cardiopulmonary function. To date, many case reports have indicated that this technology can temporarily help patients survive critical condition and to achieve a good prognosis. Case presentation: A 27-year-old male patient presented to the emergency department with sudden dyspnoea and haemoptysis. Pulmonary oedema, cardiogenic shock and cardiac arrest occurred immediately after admission, prompting VA-ECMO treatment. After the patient’s haemodynamics were stabilized, multiple endocrine neoplasia type 2 (MEN2) was detected via laboratory tests and imaging examination. After the withdrawal of VA-ECMO support, surgical resection of the lesions was performed, and a good prognosis was achieved.ConclusionVA-ECMO can be used as an emergency treatment for refractory cardiogenic shock caused by adrenal lesions. However, a large number of prospective studies are still needed to confirm its safety and efficacy and to clarify the timing of initiation and assessment of patient prognosis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2022) conducted a case report in Refractory cardiogenic shock induced by adrenal lesions (n=28). Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was evaluated on Hospital survival. VA-ECMO successfully served as an emergency bridging treatment for refractory cardiogenic shock caused by adrenal lesions, allowing for hemodynamic stabilization and subsequent definitive treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: